Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelley M Herbrich

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
British Journal of Haematology|November 27, 2018
Refining statistics clarifies leukaemic stem cell genomicsShelley M Herbrich, Keith A Baggerly, Marina Konopleva
Oncotarget|July 27, 2018
Characterization of TRKA signaling in acute myeloid leukemiaShelley M Herbrich, Sankaranarayanan Kannan, Riitta M Nolo, et al.
American Journal of Hematology|May 2, 2020
Thirty-three years later: Two distinct cases of acute lymphoblastic leukemia in one patientMarisa J L Aitken, Christopher B Benton, Feng Wang, et al.
Ebiomedicine|May 7, 2019
Pan-cancer genomic analysis links 3'UTR DNA methylation with increased gene expression in T cellsMichael H McGuire, Shelley M Herbrich, Santosh K Dasari, et al.
Antioxidants (Basel, Switzerland)|April 23, 2022
Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy EfficacySankaranarayan Kannan, Mary E Irwin, Shelley M Herbrich, et al.
Journal of Proteome Research|December 29, 2012
Statistical inference from multiple iTRAQ experiments without using common reference standardsShelley M Herbrich, Robert N Cole, Keith P West, et al.
Molecular Cancer Therapeutics|June 23, 2019
Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic LeukemiaSankaranarayanan Kannan, Marisa J L Aitken, Shelley M Herbrich, et al.
Cell|April 14, 2023
Immune checkpoint therapy-current perspectives and future directionsPadmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
NAR Cancer|December 15, 2022
Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferation in mice via altered <i>Runx1</i> splicingMarisa J L Aitken, Prerna Malaney, Xiaorui Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2014
Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancerSusan L Tucker, Kshipra Gharpure, Shelley M Herbrich, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|November 27, 2018
Refining statistics clarifies leukaemic stem cell genomicsShelley M Herbrich, Keith A Baggerly, Marina Konopleva
Oncotarget|July 27, 2018
Characterization of TRKA signaling in acute myeloid leukemiaShelley M Herbrich, Sankaranarayanan Kannan, Riitta M Nolo, et al.
American Journal of Hematology|May 2, 2020
Thirty-three years later: Two distinct cases of acute lymphoblastic leukemia in one patientMarisa J L Aitken, Christopher B Benton, Feng Wang, et al.
Ebiomedicine|May 7, 2019
Pan-cancer genomic analysis links 3'UTR DNA methylation with increased gene expression in T cellsMichael H McGuire, Shelley M Herbrich, Santosh K Dasari, et al.
Antioxidants (Basel, Switzerland)|April 23, 2022
Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy EfficacySankaranarayan Kannan, Mary E Irwin, Shelley M Herbrich, et al.
Journal of Proteome Research|December 29, 2012
Statistical inference from multiple iTRAQ experiments without using common reference standardsShelley M Herbrich, Robert N Cole, Keith P West, et al.
Molecular Cancer Therapeutics|June 23, 2019
Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic LeukemiaSankaranarayanan Kannan, Marisa J L Aitken, Shelley M Herbrich, et al.
Cell|April 14, 2023
Immune checkpoint therapy-current perspectives and future directionsPadmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
NAR Cancer|December 15, 2022
Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferation in mice via altered <i>Runx1</i> splicingMarisa J L Aitken, Prerna Malaney, Xiaorui Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2014
Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancerSusan L Tucker, Kshipra Gharpure, Shelley M Herbrich, et al.
Pageof 2